Payment overview · 2025
General Payments
$163.77
5 reported records · 3 companies
Healthcare provider profile · identity verified
Manuel E Marcano Rivera, MD
Allopathic & Osteopathic Physicians|General Practice · ARECIBO, PR · NPI 1447224746
Verified facts
What the public records show
CMS Open Payments records show Manuel E Marcano Rivera, MD received $163.77 in general payments during 2025 across 5 reported records.
Lilly USA, LLC accounted for 46.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Farxiga by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $76.23 | 46.5% | 1 | 2025 |
| Eli Lilly Export S.A. Puerto Rico Branch | Unresolved — no canonical attribution shown | $63.91 | 39.0% | 3 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $23.63 | 14.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $163.77 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MOUNJARO Normalized: mounjaro |
Drug | Eli Lilly Export S.A. Puerto Rico Branch, Lilly USA, LLC | $140.14 | 4 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Eli Lilly Export S.A. Puerto Rico Branch | $63.91 | 3 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $23.63 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 614 | 118 |
| Prednisone | Prednisone | 539 | 222 |
| Clonazepam | Clonazepam | 483 | 95 |
| Lisinopril | Lisinopril | 472 | 89 |
| Metformin Hcl | Metformin Hcl | 453 | 77 |
| Famotidine | Famotidine | 440 | 99 |
| Dexamethasone | Dexamethasone | 396 | 181 |
| Simvastatin | Simvastatin | 392 | 86 |
| Alprazolam | Alprazolam | 382 | 63 |
| Theophylline Er | Theophylline Anhydrous | 342 | 163 |
| Glipizide | Glipizide | 328 | 49 |
| Montelukast Sodium | Montelukast Sodium | 294 | 98 |
| Omeprazole | Omeprazole | 272 | 50 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 253 | 40 |
| Spironolactone | Spironolactone | 248 | 70 |
| Verapamil Er | Verapamil Hcl | 241 | 35 |
| Losartan Potassium | Losartan Potassium | 233 | 45 |
| Furosemide | Furosemide | 224 | 54 |
| Dicyclomine Hcl | Dicyclomine Hcl | 200 | 83 |
| Pantoprazole Sodium | Pantoprazole Sodium | 185 | 45 |
| Tramadol Hcl | Tramadol Hcl | 183 | 35 |
| Diclofenac Potassium | Diclofenac Potassium | 182 | 62 |
| Ibuprofen | Ibuprofen | 182 | 81 |
| Synthroid | Levothyroxine Sodium | 180 | 35 |
| Glimepiride | Glimepiride | 173 | 24 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 162 | 84 |
| Atorvastatin Calcium | Atorvastatin Calcium | 159 | 34 |
| Zolpidem Tartrate | Zolpidem Tartrate | 148 | 25 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 146 | 26 |
| Sulindac | Sulindac | 142 | 80 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 128 | 26 |
| Buspirone Hcl | Buspirone Hcl | 126 | 41 |
| Hydrochlorothiazide | Hydrochlorothiazide | 125 | 20 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 124 | 16 |
| Azithromycin | Azithromycin | 122 | 102 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 122 | 54 |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 120 | 28 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 119 | 74 |
| Piroxicam | Piroxicam | 116 | 54 |
| Carvedilol | Carvedilol | 115 | 21 |
| Levothyroxine Sodium | Levothyroxine Sodium | 109 | 25 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 108 | 41 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 108 | 16 |
| Tamsulosin Hcl | Tamsulosin Hcl | 108 | 21 |
| Cephalexin | Cephalexin | 106 | 85 |
| Quetiapine Fumarate | Quetiapine Fumarate | 105 | 19 |
| Levofloxacin | Levofloxacin | 104 | 78 |
| Metoprolol Succinate | Metoprolol Succinate | 103 | 26 |
| Januvia | Sitagliptin Phosphate | 102 | 17 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 101 | 29 |
| Fluconazole | Fluconazole | 101 | 64 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 100 | 66 |
| Ozempic | Semaglutide | 98 | 24 |
| Amlodipine Besylate | Amlodipine Besylate | 97 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 95 | 23 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 91 | 18 |
| Verapamil Hcl | Verapamil Hcl | 91 | 20 |
| Etodolac Er | Etodolac | 88 | 40 |
| Ketoconazole | Ketoconazole | 87 | 48 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 85 | 52 |
| Alendronate Sodium | Alendronate Sodium | 85 | 20 |
| Cimetidine | Cimetidine | 79 | 38 |
| Baclofen | Baclofen | 78 | 26 |
| Naproxen | Naproxen | 76 | 23 |
| Atenolol | Atenolol | 74 | 14 |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 74 | 40 |
| Eliquis | Apixaban | 73 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 73 | suppressed |
| Naproxen Sodium | Naproxen Sodium | 70 | 38 |
| Pentoxifylline | Pentoxifylline | 70 | 26 |
| Irbesartan | Irbesartan | 64 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 63 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 63 | 13 |
| Rifampin | Rifampin | 63 | 49 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 61 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 57 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 57 | 15 |
| Metoprolol Tartrate | Metoprolol Tartrate | 55 | suppressed |
| Sucralfate | Sucralfate | 55 | 22 |
| Metronidazole | Metronidazole | 54 | 27 |
| Nabumetone | Nabumetone | 54 | 19 |
| Etodolac | Etodolac | 53 | 16 |
| Aripiprazole | Aripiprazole | 51 | 15 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 51 | 39 |
| Sertraline Hcl | Sertraline Hcl | 50 | 12 |
| Doxepin Hcl | Doxepin Hcl | 48 | suppressed |
| Cefadroxil | Cefadroxil | 47 | 38 |
| Fenofibrate | Fenofibrate,micronized | 47 | 11 |
| Temazepam | Temazepam | 47 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 46 | suppressed |
| Mupirocin | Mupirocin | 46 | 29 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 45 | 11 |
| Gentamicin Sulfate | Gentamicin Sulfate | 45 | 34 |
| Loperamide | Loperamide Hcl | 45 | 21 |
| Penicillin V Potassium | Penicillin V Potassium | 45 | 38 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 43 | 33 |
| Doxazosin Mesylate | Doxazosin Mesylate | 42 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 42 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 42 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 41 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 41 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 41 | suppressed |
| Trandolapril | Trandolapril | 41 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 40 | 27 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 37 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 37 | 11 |
| Risperidone | Risperidone | 37 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 35 | suppressed |
| Glipizide Er | Glipizide | 35 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 34 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 31 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 31 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 29 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 29 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 28 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 28 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 27 | 15 |
| Humalog | Insulin Lispro | 27 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 27 | 20 |
| Amoxicillin | Amoxicillin | 26 | 14 |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 26 | 11 |
| Divalproex Sodium | Divalproex Sodium | 26 | suppressed |
| Memantine Hcl | Memantine Hcl | 26 | suppressed |
| Cilostazol | Cilostazol | 25 | suppressed |
| Benzonatate | Benzonatate | 24 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 24 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 24 | suppressed |
| Celecoxib | Celecoxib | 23 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 23 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | 21 |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Acyclovir | Acyclovir | 22 | 11 |
| Ampicillin Trihydrate | Ampicillin Trihydrate | 21 | 11 |
| Arnuity Ellipta | Fluticasone Furoate | 21 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 21 | 18 |
| Diclofenac Sodium Er | Diclofenac Sodium | 21 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 21 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 20 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 20 | 12 |
| Topiramate | Topiramate | 20 | suppressed |
| Gemfibrozil | Gemfibrozil | 19 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | 14 |
| Lansoprazole | Lansoprazole | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Lidocaine | Lidocaine | 17 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 17 | 11 |
| Meloxicam | Meloxicam | 17 | suppressed |
| Nystatin | Nystatin | 17 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 16 | suppressed |
| Ciclopirox | Ciclopirox | 16 | 13 |
| Ibu | Ibuprofen | 16 | suppressed |
| Permethrin | Permethrin | 16 | 13 |
| Solu-Medrol | Methylprednisolone Sod Succ/Pf | 16 | suppressed |
| Digoxin | Digoxin | 15 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 15 | suppressed |
| Orphenadrine Citrate Er | Orphenadrine Citrate | 15 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 15 | suppressed |
| Xarelto | Rivaroxaban | 15 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 14 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 14 | suppressed |
| Linzess | Linaclotide | 14 | suppressed |
| Lorazepam | Lorazepam | 14 | suppressed |
| Mirtazapine | Mirtazapine | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 14 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 13 | suppressed |
| Methylprednisolone | Methylprednisolone | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Bupropion Xl | Bupropion Hcl | 12 | suppressed |
| Econazole Nitrate | Econazole Nitrate | 12 | suppressed |
| Jardiance | Empagliflozin | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Chlordiazepoxide-Clidinium | Chlordiazepoxide/Clidinium Br | 11 | suppressed |
| Desonide | Desonide | 11 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 11 | suppressed |
| Finasteride | Finasteride | 11 | suppressed |
| Nalbuphine Hcl | Nalbuphine Hcl | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $163.77 · 5 records | Lilly USA, LLC | AIRSUPRA, MOUNJARO, ZEPBOUND | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error